Cargando…
Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia
BACKGROUND: Homozygous familial hypercholesterolaemia (HoFH) is characterized by a markedly increased risk of premature cardiovascular (CV) events and cardiac death. Lomitapide reduces low-density lipoprotein cholesterol (LDL-C) levels; however, the probable impact on LDL-C goals and CV events is un...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011273/ https://www.ncbi.nlm.nih.gov/pubmed/29925433 http://dx.doi.org/10.1186/s13023-018-0841-3 |